Homocysteine levels are associated with hippocampus volume in type 2 diabetic patients
暂无分享,去创建一个
Nobuoki Eshima | Hidenori Kobayashi | Minoru Fujiki | Futoshi Anan | Takayuki Masaki | Yoshikazu Umeno | Tetsunori Saikawa | Hironobu Yoshimatsu | M. Fujiki | Hidenori Kobayashi | H. Yoshimatsu | T. Masaki | T. Saikawa | T. Shimomura | N. Eshima | Tsuyoshi Shimomura | F. Anan | Y. Umeno
[1] Santhosh K. P. Kumar,et al. Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[2] N. Nagelkerke,et al. A note on a general definition of the coefficient of determination , 1991 .
[3] R. Turner,et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.
[4] C. R. Park,et al. Cognitive effects of insulin in the central nervous system , 2001, Neuroscience & Biobehavioral Reviews.
[5] A. Dominiczak,et al. 2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. , 2007, Journal of hypertension.
[6] G. Reaven. Role of Insulin Resistance in Human Disease , 1988, Diabetes.
[7] J. Ashburner,et al. Multimodal Image Coregistration and Partitioning—A Unified Framework , 1997, NeuroImage.
[8] Karl J. Friston,et al. Voxel-Based Morphometry—The Methods , 2000, NeuroImage.
[9] T. Maruyama,et al. Effects of short-term folic acid and/or riboflavin supplementation on serum folate and plasma total homocysteine concentrations in young Japanese male subjects , 2006, European Journal of Clinical Nutrition.
[10] P. Behn,et al. Hepatocyte nuclear factor 1alpha coding mutations are an uncommon contributor to early-onset type 2 diabetes in Ashkenazi Jews. , 1998, Diabetes.
[11] D. Bennett,et al. From Healthy Aging to Early Alzheimer's Disease: In Vivo Detection of Entorhinal Cortex Atrophy , 2000, Annals of the New York Academy of Sciences.
[12] E. Giltay,et al. Insulin resistance is associated with elevated plasma total homocysteine levels in healthy, non-obese subjects. , 1998, Atherosclerosis.
[13] D. Fuchs,et al. Hyperhomocysteinemia in dementia , 2000, Neurobiology of Aging.
[14] S. Doré,et al. Distribution and levels of [125I]IGF-I, [125I]IGF-II and [125I]insulin receptor binding sites in the hippocampus of aged memory-unimpaired and -impaired rats , 1997, Neuroscience.
[15] C. Culmsee,et al. Homocysteine Elicits a DNA Damage Response in Neurons That Promotes Apoptosis and Hypersensitivity to Excitotoxicity , 2000, The Journal of Neuroscience.
[16] H. Iso,et al. Effects of serum B vitamins on elevated plasma homocysteine levels associated with the mutation of methylenetetrahydrofolate reductase gene in Japanese. , 2002, Atherosclerosis.
[17] B. McEwen,et al. Glucose transporter expression in the central nervous system: relationship to synaptic function. , 2004, European journal of pharmacology.
[18] D. Amaral,et al. Hippocampal abnormalities in amnesic patients revealed by high-resolution magnetic resonance imaging , 1989, Nature.
[19] L. Fink,et al. Effects of a high-fat-sucrose diet on enzymes in homocysteine metabolism in the rat. , 2000, Metabolism: clinical and experimental.
[20] S. Folstein,et al. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.
[21] L. Reagan,et al. Insulin signaling effects on memory and mood. , 2007, Current opinion in pharmacology.
[22] A. Dominiczak,et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) , 2007, European heart journal.
[23] Kevin M Bradley,et al. Minimal hippocampal width relates to plasma homocysteine in community-dwelling older people. , 2002, Age and ageing.
[24] P A Wolf,et al. Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association. , 2001, Circulation.
[25] V. Sánchez-Margalet,et al. Homocysteine thiolactone inhibits insulin-stimulated DNA and protein synthesis: possible role of mitogen-activated protein kinase (MAPK), glycogen synthase kinase-3 (GSK-3) and p70 S6K phosphorylation. , 2005, Journal of molecular endocrinology.
[26] P. J. Koudstaal,et al. Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI , 2003, Diabetologia.
[27] J. Lindsay,et al. Vascular dementia : incidence and risk factors in the Canadian study of health and aging. , 2000, Stroke.
[28] E. Mariani,et al. Homocysteine and cognitive function in healthy elderly community dwellers in Italy. , 2003, The American journal of clinical nutrition.
[29] A. Folsom,et al. Multiple Metabolic Syndrome Is Associated With Lower Heart Rate Variability: The Atherosclerosis Risk in Communities Study , 1998, Diabetes Care.
[30] S. Baxendale,et al. Amnesia in temporal lobectomy patients: Historical perspective and review , 1998, Seizure.
[31] A Hofman,et al. Homocysteine and brain atrophy on MRI of non-demented elderly. , 2003, Brain : a journal of neurology.
[32] Nobuoki Eshima,et al. Abdominal visceral fat accumulation is associated with hippocampus volume in non-dementia patients with type 2 diabetes mellitus , 2010, NeuroImage.
[33] V. Sánchez-Margalet,et al. Homocysteine thiolactone inhibits insulin signaling, and glutathione has a protective effect. , 2001, Journal of molecular endocrinology.
[34] G. Reaven. Banting lecture 1988. Role of insulin resistance in human disease. , 1988, Diabetes.
[35] L. Launer,et al. Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study. , 2002, Diabetes.
[36] P. Raskin,et al. A double blind comparison of the effects of amlodipine and enalapril on insulin sensitivity in hypertensive patients. , 1999, American journal of hypertension.
[37] Takashi Asada,et al. Voxel-based morphometry to discriminate early Alzheimer's disease from controls , 2005, Neuroscience Letters.
[38] M. Mattson,et al. Folic Acid Deficiency and Homocysteine Impair DNA Repair in Hippocampal Neurons and Sensitize Them to Amyloid Toxicity in Experimental Models of Alzheimer's Disease , 2002, The Journal of Neuroscience.
[39] M. Brosnan,et al. Effects of streptozotocin-induced diabetes and of insulin treatment on homocysteine metabolism in the rat. , 1998, Diabetes.
[40] T. Shoji,et al. Impact of insulin resistance and nephropathy on homocysteine in type 2 diabetes. , 2001, Diabetes care.
[41] C. Jack,et al. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment , 1999, Neurology.
[42] C. Jack,et al. Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease , 1998, Neurology.
[43] G. Fulcher,et al. The relationship among homocysteine, creatinine clearance, and albuminuria in patients with type 2 diabetes. , 2001, Diabetes care.
[44] D. Alkon,et al. Brain Insulin Receptors and Spatial Memory , 1999, The Journal of Biological Chemistry.
[45] A. Rudich,et al. Oxidative Stress Disrupts Insulin-induced Cellular Redistribution of Insulin Receptor Substrate-1 and Phosphatidylinositol 3-Kinase in 3T3-L1 Adipocytes , 1999, The Journal of Biological Chemistry.
[46] S. Woods,et al. Intracerebroventricular insulin enhances memory in a passive-avoidance task , 2000, Physiology & Behavior.